International Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled Exploratory Clinical Trial of Daridorexant in Idiopathic and Parkinson's Disease-Related REM Sleep Behavior Disorder: A Multimodal Efficacy and Mechanism Study

Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133902) titled 'A Randomized, Double-Blind, Placebo-Controlled Exploratory Clinical Trial of Daridorexant in Idiopathic and Parkinson's Disease-Related REM Sleep Behavior Disorder: A Multimodal Efficacy and Mechanism Study' on Oct. 9.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

Condition: REM sleep behavior disorder, RBD

Intervention: iRBD-Dali Lesheng Group:Dali Lei Sheng tablets: Take orally 30 minutes before bedtime, once nightly. Week 1: 25 mg per night Weeks 2-12: Increase to 50 mg per night for pati...